213 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
TMO Thermo Fisher Scientific Inc $238.46 $96.05B N/A
Article Searches
Bio-Rad (Bio) Q3 Earnings Beat Estimates on All-Line Growth http://www.zacks.com/stock/news/598494/bio-rad-bio-q3-earnings-beat-estimates-on-all-line-growth?cid=CS-ZC-FT-analyst_blog|earnings_article-598494 Nov 01, 2019 - Growing strength in many of Bio-Rad's (Bio) key product lines across major geographic regions buoys investors' optimism on the stock.
Surmodics (SRDX) Q4 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/602138/surmodics-srdx-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-602138 Nov 04, 2019 - Surmodics (SRDX) continues to gain from core Medical Devices unit, which saw significant contribution from the SurVeil deal with Abbott in Q4.
Inogen's (INGN) Q3 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/606318/inogens-ingn-q3-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-606318 Nov 06, 2019 - Softness in domestic and international business-to-business revenues impact Inogen's (INGN) Q3 results.
Insulet (PODD) Beats on Q3 Earnings, Ups '19 Revenue View http://www.zacks.com/stock/news/608214/insulet-podd-beats-on-q3-earnings-ups-19-revenue-view?cid=CS-ZC-FT-analyst_blog|earnings_article-608214 Nov 07, 2019 - Insulet's (PODD) year-over-year improvement in Q3 revenues on the solid uptake of Omnipod system both in the United States and across international markets looks promising.
Cardinal Health (CAH) Q1 Earnings & Revenues Beat Estimates http://www.zacks.com/stock/news/608379/cardinal-health-cah-q1-earnings-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-608379 Nov 07, 2019 - Cardinal Health (CAH) Q1 results benefit revenue growth and strong segmental performance. However, contraction in gross margin remains a concern.
DENTSPLY SIRONA (XRAY) Beats on Q3 Earnings, Ups '19 View http://www.zacks.com/stock/news/608511/dentsply-sirona-xray-beats-on-q3-earnings-ups-19-view?cid=CS-ZC-FT-analyst_blog|earnings_article-608511 Nov 07, 2019 - DENTSPLY SIRONA (XRAY) gains from solid segmental contributions in Q3.
DexCom (DXCM) Earnings and Revenues Beat Estimates in Q3 http://www.zacks.com/stock/news/610111/dexcom-dxcm-earnings-and-revenues-beat-estimates-in-q3?cid=CS-ZC-FT-analyst_blog|earnings_article-610111 Nov 08, 2019 - DexCom's (DXCM) Q3 earnings benefit from higher revenues, solid performing Sensor and Transmitter segments and strong 2019 outlook. However, contraction in gross margin remains a woe.
Here's Why You Should Buy Thermo Fisher (TMO) Stock Now http://www.zacks.com/stock/news/636931/heres-why-you-should-buy-thermo-fisher-tmo-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-636931 Nov 25, 2019 - Investors continue to be optimistic about Thermo Fisher (TMO) on its stellar performance.
Here's Why You Should Hold on to HealthEquity (HQY) for Now http://www.zacks.com/stock/news/653875/heres-why-you-should-hold-on-to-healthequity-hqy-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-653875 Dec 04, 2019 - Buoyed by a solid fiscal third quarter, HealthEquity (HQY) raises its fiscal 2020 view.
What's in the Cards for Cantel Medical (CMD) in Q1 Earnings? http://www.zacks.com/stock/news/654062/whats-in-the-cards-for-cantel-medical-cmd-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-654062 Dec 04, 2019 - Better-than-expected performance at both Medical and Dental segments is likely to have driven Cantel Medical (CMD) in Q1 earnings.

Pages: 1...16171819202122

<<<Page 21